Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure (NCT06310031)
Investigation of a Novel, magNetically Levitated VAD for the Treatment of refractOry Left Ventricular heArT failurE
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham Hospital — Birmingham, Alabama
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (47 Sites)
Showing the first 25 of 47 sites.
- University of Alabama at Birmingham Hospital — Birmingham, Alabama
- Baptist Health Medical Center-Little Rock — Little Rock, Arkansas
- Cedars-Sinai Medical Center — Los Angeles, California
- UF Health Shands Hospital — Gainesville, Florida
- Advent Health — Orlando, Florida
- Piedmont Healthcare — Atlanta, Georgia
- Emory University — Atlanta, Georgia
- Advocate Christ Medical Center — Chicago, Illinois
- Northwestern University — Chicago, Illinois
- University of Chicago — Chicago, Illinois
- Ascension St. Vincent Hospital - Indianapolis — Indianapolis, Indiana
- The University Of Kansas Medical Center — Kansas City, Kansas
- University of Kentucky — Lexington, Kentucky
- University of Louisville — Louisville, Kentucky
- University of Maryland Medical Center — Baltimore, Maryland
- The Johns Hopkins Hospital — Baltimore, Maryland
- Tufts Medical Center — Boston, Massachusetts
- Massachusetts General Hospital — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Henry Ford Health — Detroit, Michigan
- Corewell Health Grand Rapids Hospital — Grand Rapids, Michigan
- Abbott Northwestern Hospital — Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota
- WashU Medicine — St Louis, Missouri
- University of Nebraska Medical Center — Omaha, Nebraska
📞 Contact the Study Coordinator
Phone: (201) 401-6539
Email: pranesh.thirukkonda@briohealth.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiovascular Diseases
- The Jackson Heart Study of Cardiovascular Disease Among African Americans — Jackson, Mississippi
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials — Toronto, Ontario
- Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study — Ottawa, Ontario
- Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption — Davis, California
- Black Women's Life Experience On Cardiovascular Health Via Ongoing Monitoring — Arlington, Texas
- Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT) — Baltimore, Maryland
Explore by condition: All Cardiovascular Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.